Polymerase Chain Reaction (PCR) Technologies Market Report 2026

The polymerase chain reaction (pcr) technologies market size has grown rapidly in recent years. It will grow from $16.23 billion in 2025 to $18.18 billion in 2026 at a compound annual growth rate (CAGR) of 12%. The growth in the historic period can be attributed to increasing molecular biology research activities, growth in infectious disease diagnostics, availability of advanced pcr reagents and consumables, expansion of biotech research funding, improved laboratory automation.

The polymerase chain reaction (pcr) technologies market size is expected to see rapid growth in the next few years. It will grow to $26.8 billion in 2030 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to increasing investment in next-generation pcr technologies, rising demand for decentralized diagnostics, expansion of environmental and food testing applications, growing adoption of ai-enabled pcr analysis, increased focus on high-sensitivity molecular assays. Major trends in the forecast period include growing adoption of advanced pcr platforms, rising demand for integrated pcr software solutions, expansion of point-of-care pcr applications, increasing use of digital pcr technologies, enhanced automation of pcr workflows.

The growing prevalence of infectious diseases is expected to drive the growth of the polymerase chain reaction (PCR) technologies market going forward. Infectious diseases are illnesses caused by pathogenic microorganisms such as bacteria, viruses, parasites, or fungi that can spread directly or indirectly between individuals. The rising burden of infectious diseases reflects increasing global health challenges driven by factors such as globalization, urbanization, antimicrobial resistance, and environmental changes. PCR technologies help address infectious diseases by detecting and amplifying specific genetic material from pathogens, enabling accurate identification and diagnosis with high sensitivity. For instance, in 2025, according to the World Health Organization (WHO), a Switzerland-based specialized agency of the United Nations, an estimated 10.7 million people worldwide fell ill with tuberculosis in 2024, corresponding to 131 incident cases per 100,000 population. Therefore, the increasing prevalence of infectious diseases is contributing to the growth of the PCR technologies market.

Major companies operating in the PCR technologies market are focusing on the development of advanced technological solutions, such as next generation quantitative polymerase chain reaction technologies, to enhance accuracy, sensitivity, and operational efficiency in molecular diagnostics. Quantitative polymerase chain reaction technology enables the measurement of specific DNA sequences in real time during amplification, making it a critical tool across medical and scientific applications. For instance, in November 2023, F. Hoffmann-La Roche AG, a Switzerland-based biotechnology company, introduced the LightCycler PRO System, a next generation qPCR system designed to support evolving clinical needs in molecular diagnostics and address public health challenges. The system is positioned as an advanced qPCR platform for both clinical and research use, offering improved performance, usability, and reliability while bridging translational research and in vitro diagnostics. It leverages established technologies to ensure precision and consistency required for accurate patient diagnosis and informed clinical decision making.

In May 2023, Transformative Biotech LLC, a US-based biotechnology startup, acquired Summit Biolabs for an undisclosed amount. Through this acquisition, Transformative Biotech aims to advance rapid and highly accurate direct to PCR technologies, with the potential to significantly impact the biotechnology sector. Summit Biolabs is a US-based biotechnology company specializing in innovative molecular diagnostic solutions and direct to PCR technologies.

Major companies operating in the polymerase chain reaction (pcr) technologies market are F Hoffmann La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, GE Healthcare Technologies LLC, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., bioMérieux SA, Beckman Coulter Inc., Sysmex Corporation, Bio Rad Laboratories Inc., QIAGEN N.V., BGI Genomics Co. Ltd., Cepheid, Takara Bio Inc., Promega Corporation, Analytik Jena AG, LGC Biosearch Technologies, Meridian Bioscience Inc., Canon Medical Systems Corporation, Eppendorf AG.

North America was the largest region in the PCR technologies market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the polymerase chain reaction (pcr) technologies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the polymerase chain reaction (pcr) technologies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the polymerase chain reaction technologies market by increasing costs of imported reagents, consumables, thermal cyclers, digital PCR systems, and analytical software components. Hospitals, diagnostic laboratories, and biotech firms in North America and Europe are most affected due to global sourcing dependencies, while Asia-Pacific faces higher production costs for export-oriented PCR platforms. These tariffs are elevating operational expenses and slowing technology upgrades. At the same time, they are supporting domestic manufacturing of PCR reagents, regional equipment assembly, and local software development for molecular diagnostics solutions.

The polymerase chain reaction (pcr) technologies market research report is one of a series of new reports that provides polymerase chain reaction (pcr) technologies market statistics, including polymerase chain reaction (pcr) technologies industry global market size, regional shares, competitors with a polymerase chain reaction (pcr) technologies market share, detailed polymerase chain reaction (pcr) technologies market segments, market trends and opportunities, and any further data you may need to thrive in the polymerase chain reaction (pcr) technologies industry. This polymerase chain reaction (pcr) technologies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Polymerase chain reaction (PCR) technologies are laboratory methods used to amplify and analyze DNA sequences. These techniques are essential tools in molecular biology and are widely applied across areas such as genetic testing, diagnostics, forensic analysis, and scientific research.

The main products within PCR technologies include reagents and consumables, instruments, software, and services. Reagents and consumables consist of materials, chemicals, and supplies used in scientific experiments, research activities, or industrial processes and are typically consumed during testing or analysis. The key technologies include real-time polymerase chain reaction, conventional polymerase chain reaction, reverse transcription polymerase chain reaction, digital polymerase chain reaction, multiplex real-time polymerase chain reaction, hot start polymerase chain reaction, and others. These technologies are used in a variety of applications such as gene expression analysis, genetic sequencing, genotyping, nucleic acid synthesis, standard validation, point-of-care diagnostics, environmental testing, and others. They are utilized by end users including hospitals and diagnostic centers, research laboratories and academic institutions, pharmaceutical and biotechnology companies, and others.

The PCR technologies market consists of revenues earned by entities by providing services such as gene expression analysis, pathogen detection, viral load quantification, reverse transcriptase enzyme, custom assay development, clinical diagnostics, and technical support. The market value includes the value of related goods sold by the service provider or included within the service offering. The PCR technologies market also includes sales of thermal cyclers, quantitative polymerase chain reaction (qPCR) instruments, digital polymerase chain reaction systems, reverse transcription polymerase chain reaction (RT-PCR) kits, reagents and consumables, master mixes, polymerase chain reaction plates and tubes, polymerase chain reaction cleanup and purification kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.